跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hospira irinotecan hydrochloride trihydrate Trihydrate for Injection 40mg/2mL vial - TGA Drug Approval Details
Approvals
/
TGA
/
Hospira irinotecan hydrochloride trihydrate Trihydrate for Injection 40mg/2mL vial
Approved
STANDARD
Hospira irinotecan hydrochloride trihydrate Trihydrate for Injection 40mg/2mL vial
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
df14029801ce17d2
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
df14029801ce17d2
Product Name
Hospira irinotecan hydrochloride trihydrate Trihydrate for Injection 40mg/2mL vial
Artg Id
140609
Artg Name
Hospira irinotecan hydrochloride trihydrate Trihydrate for Injection 40mg/2mL vial
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2007-06-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
df14029801ce17d2
Type
Standard
Back to TGA Approvals
